Skip to main content
. 2023 Nov 14;2023(11):CD013303. doi: 10.1002/14651858.CD013303.pub2

5. Outcome category: self‐efficacy.

Study ID Health topic Measure No. of participants Time point(s) Intervention arm
Mean (SD)*
Control arm
Mean (SD)*
Notes
1 Culturally and literacy adapted self‐management programme vs no health literacy intervention
Rosal 2011 Diabetes type 2 Self‐efficacy in diabetes management; LSESLD
(17 items, 17 to 68, higher score is better)
IG: 124
CG: 128
4 months after randomisation 0.448 (0.362 to 0.534) 0.132 (0.040 to 0.219) Mean (range) is reported
P < 0.001
For meta‐analysis, the final SD was substituted with the reported baseline SD (Analysis 1.9)
12 months after randomisation 0.448 (0.0348 to 0.548) 0.213 (0.113 to 0.313) P = 0.001
van Servellen 2005 HIV Self‐efficacy for HIV medication adherence; adherence behaviours baseline questionnaire (item from the ACTG)
(1 question on certainty to take medications correctly, 0 = not at all sure to 3 = extremely sure, higher scores are better)
IG: 41
CG: 40
At 6 weeks after randomisation 0.27 (0.92) ‐0.08 (0.92) Intervention group: P ≥ 0.10
Change scores are reported
IG: 34
CG: 35
At 6 months after randomisation 0.12 (0.95) ‐0.06 (0.59) Change scores are reported
2 Culturally and literacy adapted self‐management programme vs written information on the same topic
Kim 2009 Diabetes type 2 Adapted Stanford Chronic Disease Self‐Efficacy Scale
(8 x 10‐point Likert items, 0 to 80, 1 = not confident at all, 4 = very confident, higher scores are better)
IG: 40
CG: 39
18 weeks after randomisation 8.7 (11.4) 2.6 (15.0) Change scores are reported
P = 0.02
30 weeks after randomisation 6.6 (14.4) ‐0.9 (15.1) Change scores are reported
P = 0.01
Kim 2014 HBP Self‐efficacy in managing high blood pressure; questionnaire adapted from the HBP belief scale
(8 items, 4‐point Likert scale, 1 = not confident at all, 4 = very confident, 8 to 32, higher scores are better)
IG: 184
CG: 185
12 months after randomisation (immediately post‐intervention) 26.6 (3.2) 25.4 (3.7) Cluster‐RCT; data have been re‐analysed for meta‐analysis using the appropriate unit of analysis with the use of the ICC reported by Han 2017 (see Analysis 2.23; Analysis 2.25)
Group x time
P = 0.001 (at 12 months)
18 months after randomisation (6‐month follow‐up) 25.9 (3.7) 26.1 (3.9)
Kim 2020 Diabetes type 2 Adapted Stanford Chronic Disease Self‐Efficacy Scale
(8 items, 10‐point Likert scale, 0 to 80, 1 = not confident at all, 4 = very confident, higher scores are better)
IG: 105
CG: 104
12 months after randomisation 58.6 (SE 1.2) 46.5 (SE 1.6) P < 0.001
Rosal 2005 Diabetes type 2 IMDSES
(26 items, 4‐point Likert‐scale, 1 = "low confidence" to 4 = "high confidence", 26 to 104, higher scores are better)
IG: 15
CG: 10
3 months after randomisation (immediately post‐intervention) Self‐efficacy for
(1) Diet 0.03 (0.4)
(2) Exercise 0.11 (0.9)
(3) Self‐monitoring 0.3 (1.0)
(4) Oral glycaemic agents ‐0.1 (0.3)
(5) Insulin ‐0.14 (1.3)
Self‐efficacy for
(1) Diet 0.44 (0.3)*
(2) Exercise 0.24 (0.6)
(3) Self‐monitoring –0.3 (0.7)
(4) Oral glycaemic agents 0 (0)
(5) Insulin –0.2 (0.5)
Change scores are reported
No composite score reported. For meta‐analysis, a single score was calculated (see Analysis 2.23)
6 months after randomisation (4.5 months post‐intervention) (1) Diet 0.10 (0.6)
(2) Exercise 0.04 (0.6)
(3) Self‐monitoring 0.30 (1.0)
(4) Oral glycaemic agents 0.04 (0.1)
(5) Insulin 0.01 (0.6)
(1) Diet 0.13 (0.4)
(2)Exercise –0.14 (1.0)
(3) Self‐monitoring –0.07 (0.7)
(4) Oral glycaemic agents –0.25 (0.5)
(5) Insulin –0.27 (0.4)
3 Culturally adapted health literacy skills building course vs unrelated health literacy intervention
Elder 1998 Nutrition/cardiovascular health Self‐efficacy to change one's diet
(5 items, 1 to 3, higher score is better)
IG: 133
CG: 157
3 months post‐intervention 2.29 2.25 No difference
Cluster‐RCT; unadjusted values are reported
At 6‐month follow‐up 2.30 2.27
5 Culturally and literacy adapted audio‐/visual education without personal feedback vs no health literacy intervention
Hernandez 2013 Depression Self‐efficacy to identify the need for treatment scale
(3 items, 5‐point Likert scale, 1 = not sure, 5 = very sure, 0 to 15, higher scores are better)
IG: 70
CG: 63
Immediately post‐intervention 3.64 (3.36) 0.13 (2.35) Change scores are reported
P < 0.001
6 Culturally and literacy adapted audio‐/visual education without personal feedback vs written information on the same topic
Gwede 2019 Colorectal cancer Self‐efficacy for screening using FIT
(6 items, 6 to 30, higher scores indicating higher levels of self‐efficacy)
IG: 27
CG: 36
At 3‐month follow‐up 29.7 (1.0) 29.5 (1.3) P = 0.039
Poureslami 2016b (4‐arms, COPD) COPD COPD Self‐Efficacy Scale (short version)
(5 items, 5‐point Likert‐scale, 1 = not at all confident to 5 = totally confident, higher scores are better)
Group 3: 29
Group 4: 14
3 months post‐intervention (1) Prepared to manage COPD
Group 3 vs Group 4
0.87 (0.04 to 1.71), P < 0.05
(2) Perception of being informed about COPD
Group 3 vs Group 4
0.12 (‐0.65 to 0.90), P < 0.05
(3) Remain calm when facing a worsening of COPD
Group 3 vs Group 4
0.28 (‐0.54 to 1.11), N/S
(4) Ability to achieve goals in managing COPD
Group 3 vs Group 4
1.05 (0.08 to 2.02), P < 0.05
(5) Ability to self‐manage COPD symptoms
Group 3 vs Group 4
0.38 (‐1.18 to 0.41), P < 0.05
No composite score reported
MD (95% CI), P values are reported
No difference between female and male participants
Payán 2020 Breast cancer Self‐efficacy in accessing breast cancer‐related advice or information
(1 item, "Overall, how confident are you that you could get advice or information about breast cancer if you needed it?”, 5‐point Likert scale 1 = "completely confident" to 3 = "not confident at all" (3), higher scores are better)
IG 1: 79
IG 2: 79
CG: 82
Immediately post‐intervention IG 1: 0.87 (0.34)
IG 2: 0.89 (0.32)
IG 1, 2: 0.88 (0.33)
0.80 (0.40) Final values were obtained from study authors
IG 1 and IG 2 were combined to create a single pairwise comparison
IG 1: 67
IG 2: 61
CG: 65
At 3‐month follow‐up IG 1: 0.67 (0.47)
IG 2: 0.88 (0.33)
IG 1, 2: 0.77 (0.42)
0.75 (0.44)
Unger 2013 Depression Self‐efficacy to identify depression
(2 items, 10‐point Likert scale, 1 = "not at all confident" to 10 = "very confident", higher scores are better)
IG: 69
CG: 70
Immediately post‐intervention t = 4.54, P < 0.05 t = 3.16, P < 0.05
At 1‐month follow‐up t = 3.31, P < 0.05 t = 3.00, P < 0.05 "[T]he data collectors reported that several students shared their photonovel with students in the text pamphlet group after the posttest." (Unger 2013, p. 405).
Valdez 2018 Cervical cancer/Pap testing Self‐efficacy regarding Pap smear
(1 item, "Can get a pap smear if needed", yes/no)
IG: 383
CG: 344
6‐month follow‐up n: 356, 93 % n: 314, 91 % P = 0.40

* Unadjusted mean (SD) if not otherwise reported.

ACTG: Adult AIDS Clinical Trials Group; CG: control group; COPD: chronic obstructive pulmonary disease; FIT: faecal immunochemical test; HBP: high blood pressure; IG: intervention group; IMDSES: Insulin Management Self‐Efficacy Scale; LSESLD: Lifestyle Self‐Efficacy Scale for Latinos with Diabetes; MD (95% CI): mean difference (95% confidence interval); N/S: not significant; SD: standard deviation; SE: standard error ; Pap: Papanicolaou